Home›People›Arun Menawat
AM

Arun Menawat

Chairman at Firefly Neuroscience.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Sep 29, 2026·Suggest an edit

About Arun Menawat

Arun Menawat is a chairman at Firefly Neuroscience.

Arun Menawat reports to the SEC as a director or officer of 3 public companies, including Stereotaxis (STXS) and Profound Medical (PROF).

Arun Menawat first appears on SEC filings in 2016.

Experience

This experience comes from SEC filings. The years are when the filings name Arun Menawat in the role, so the role may have started earlier or lasted longer.

Firefly Neuroscience, Inc.
Chairman
2023 – 2026 · Public company (AIFF)
Brain assessment devices that help clinicians measure and track brain function.
Stereotaxis, Inc.
Director
2016 – 2026 · Public company (STXS)
Profound Medical Corp.
CEO and director
2025 · Public company (PROF)

Key Colleagues at Startups

The people Arun Menawat works with at each company, as listed on that company's latest Form D.

Firefly Neuroscience, Inc. · Form D, Mar 13, 2026
SV
Stella Vnook
Director
GI
Gil Issachar
Chief Technology Officer
BP
Brian Posner
Director
PK
Paul Krzywicki
Chief Financial Officer
DD
David DeCaprio
Executive officer and director
GL
Greg Lipshitz
Executive officer and director

Sources

  1. SECFirefly Neuroscience, Inc. Form D, filed Mar 13, 2026
  2. SECForms 3, 4 and 5 filed by Arun Menawat (SEC filer 1685893)